Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome. - Samaha,FF.; Szapary,PO.; Iqbal,N.; Williams,MM.; Bloedon,LT.; Kochar,A.; Wolfe,ML.; Rader,DJ. (Arterioscler Thromb Vasc Biol, 2006)